Literature DB >> 3096719

Production of specific antibodies against protein A fusion proteins.

B Löwenadler, B Nilsson, L Abrahmsén, T Moks, L Ljungqvist, E Holmgren, S Paleus, S Josephson, L Philipson, M Uhlén.   

Abstract

The gene for Staphylococcal protein A was fused to the coding sequence of bacterial beta-galactosidase, alkaline phosphatase and human insulin-like growth factor I (IGF-I). The fusion proteins, expressed in bacteria, were purified by affinity chromatography on IgG-Sepharose and antibodies were raised in rabbits. All three fusion proteins elicited specific antibodies against both the inserted protein sequences and the protein A moiety. In the case of IGF-I, the protein A moiety in the fusion protein may act as an adjuvant since native IGF-I alone is a poor immunogen. The results suggest that the protein A fusion system can be used for efficient antibody production against peptides or proteins expressed from cloned or synthetic genes. To facilitate such gene fusions a set of optimized vectors have been constructed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3096719      PMCID: PMC1167125          DOI: 10.1002/j.1460-2075.1986.tb04509.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  33 in total

1.  Recombinant plasmid obtained from two different, compatible staphylococcal plasmids.

Authors:  S Iordănescu
Journal:  J Bacteriol       Date:  1975-11       Impact factor: 3.490

2.  Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay.

Authors:  R W Furlanetto; L E Underwood; J J Van Wyk; A J D'Ercole
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

3.  Staphylococcal protein A consists of five IgG-binding domains.

Authors:  T Moks; L Abrahmsén; B Nilsson; U Hellman; J Sjöquist; M Uhlén
Journal:  Eur J Biochem       Date:  1986-05-02

4.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

5.  Transformation and preservation of competent bacterial cells by freezing.

Authors:  D A Morrison
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

6.  The release of enzymes by osmotic shock from Escherichia coli in exponential phase.

Authors:  N G Nossal; L A Heppel
Journal:  J Biol Chem       Date:  1966-07-10       Impact factor: 5.157

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  Antibodies reactive with native lysozyme elicited by a completely synthetic antigen.

Authors:  R Arnon; E Maron; M Sela; C B Anfinsen
Journal:  Proc Natl Acad Sci U S A       Date:  1971-07       Impact factor: 11.205

9.  Cellular cooperation in lymphocyte activation. IV. Requirement of cell-to-cell interaction for the activation of human T and B lymphocytes by protein A.

Authors:  T Kasahara; K Kin; Y Itoh; T Kawai; M Morita; K Shioiri-Nakano
Journal:  Cell Immunol       Date:  1980-01       Impact factor: 4.868

10.  The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin.

Authors:  E Rinderknecht; R E Humbel
Journal:  J Biol Chem       Date:  1978-04-25       Impact factor: 5.157

View more
  10 in total

1.  Enzyme-linked immunosorbent assay for Escherichia coli heat-stable enterotoxin type II.

Authors:  C Handl; B Rönnberg; B Nilsson; E Olsson; H Jonsson; J I Flock
Journal:  J Clin Microbiol       Date:  1988-08       Impact factor: 5.948

2.  Identification of two mannoproteins released from cell walls of a Saccharomyces cerevisiae mnn1 mnn9 double mutant by reducing agents.

Authors:  I Moukadiri; L Jaafar; J Zueco
Journal:  J Bacteriol       Date:  1999-08       Impact factor: 3.490

3.  Towards a recombinant vaccine against diphtheria toxin.

Authors:  K Lobeck; P Drevet; M Léonetti; C Fromen-Romano; F Ducancel; E Lajeunesse; C Lemaire; A Ménez
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

4.  Immunogenicity and antigenicity in rabbits of a repeated sequence of Plasmodium falciparum antigen Pf155/RESA fused to two immunoglobulin G-binding domains of staphylococcal protein A.

Authors:  A Sjölander; S Ståhl; P A Nygren; L Aslund; N Ahlborg; B Wåhlin; A Scherf; K Berzins; M Uhlén; P Perlmann
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

5.  Overproduction and purification of SulA fusion protein in Escherichia coli and its degradation by Lon protease in vitro.

Authors:  S Sonezaki; Y Ishii; K Okita; T Sugino; A Kondo; Y Kato
Journal:  Appl Microbiol Biotechnol       Date:  1995 May-Jun       Impact factor: 4.813

6.  A protein fragment of streptococcal cell surface antigen I/II which prevents adhesion of Streptococcus mutans.

Authors:  G H Munro; P Evans; S Todryk; P Buckett; C G Kelly; T Lehner
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

7.  Efficient expression of a Trypanosoma cruzi antigen in Escherichia coli and Staphylococcus aureus and its rapid purification.

Authors:  J I Moreno; M Seigelchifer; J Zorzópulos
Journal:  World J Microbiol Biotechnol       Date:  1991-05       Impact factor: 3.312

8.  Identification of regulatory residues of the yeast adenylyl cyclase.

Authors:  G Feger; E De Vendittis; A Vitelli; P Masturzo; R Zahn; A C Verrotti; C Kavounis; G P Pal; O Fasano
Journal:  EMBO J       Date:  1991-02       Impact factor: 11.598

9.  Intracellular localization of the P21rho proteins.

Authors:  P Adamson; H F Paterson; A Hall
Journal:  J Cell Biol       Date:  1992-11       Impact factor: 10.539

10.  A novel adjuvant-free H fusion system for the production of recombinant immunogens in Escherichia coli: Its application to a 12 kDa antigen from Cryptosporidium parvum.

Authors:  Sofia J Costa; Pedro Silva; André Almeida; Antónia Conceição; Lucília Domingues; António Castro
Journal:  Bioengineered       Date:  2013-08-09       Impact factor: 3.269

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.